PATENT CLAIM ANALYSIS

Application Number: 15893456
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["435", "006120"]

Abstract:
Disclosed herein are methods and compositions that can be used to treat and diagnose parkinsonism, for example Parkinson's disease, and uses for the same.

Claim (Index 36):
A method of diagnosing a presence or increased risk of parkinsonism in a subject, comprising:\n receiving at least one sample derived from said subject, wherein said sample is selected from the group consisting of stool, urine, intestinal endothelial biopsy tissue, enteric nervous system biopsy tissue, and an in vitro culture of any of the foregoing, detecting a presence and/or abnormal level of one or more bacterial amyloid-producing bacterial species in the subject by at least one method selected from the group consisting of: direct culture, antibody binding, ELISA, western blot, lateral flow assay, no-wash assay, nucleic acid sequencing, PCR, RT-PCR, and qPCR, and wherein the presence and/or abnormal level of the one or more bacterial amyloid-producing bacterial species indicates that the subject is suffering from or at increased risk of developing parkinsonism.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 88.0
- Lexical Diversity: 1.16667
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14407568', '15324141', '10699517', '14119319', '14472036']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5543438197593733
- 35 USC 102 Novelty (BERT): 0.490405964529533
- Combined Prediction Score: 0.5479500342363893
- Mean Citation Score: 168.802842
- Max Citation Score: 192.21553
- Similarity Product: 124.58791508817852

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test